Journal
DEVELOPMENTAL CELL
Volume 21, Issue 2, Pages 288-300Publisher
CELL PRESS
DOI: 10.1016/j.devcel.2011.06.022
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research [MOP 64354]
- Heart and Stroke Foundation of British Columbia
- Yukon
- Genome Canada and Genome British Columbia
Ask authors/readers for more resources
The heart is the most common site of congenital defects, and valvuloseptal defects are the most common of the cardiac anomalies seen in the newborn. The process of endothelial-to-mesenchymal transition (EndMT) in the cardiac cushions is a required step during early valve development, and Notch signaling is required for this process. Here we show that Notch activation induces the transcription of both subunits of the soluble guanylyl cyclase (sGC) heterodimer, GUCY1A3 and GUCY1 B3, which form the nitric oxide receptor. In parallel, Notch also promotes nitric oxide (NO) production by inducing Activin A, thereby activating a PI3-kinase/Akt pathway to phosphorylate eNOS. We thus show that the activation of sGC by NO through a Notch-dependent autocrine loop is necessary to drive early EndMT in the developing atrioventricular canal (AVC).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available